The year held a number of surprises, including a few negative studies, as well as a big win for Impella in DanGer Shock.

Windtree Therapeutics, Inc. (NasdaqCM: WINT) recently showcased promising data on istaroxime, an investigational treatment ...

Windtree Therapeutics (WINT) announced that Alexandre Mebazaa, MD, one of the world’s recognized leaders in cardiogenic shock, gave a ...

Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, today announced that ...

Similarly, the Impella 5.5 with SmartAssist System is approved for short-term use of up to 14 days for paediatric patients weighing at least 30kg, also addressing cardiogenic shock under similar ...

The FDA has opened up the use of Johnson & Johnson’s miniaturized heart pumps to certain pediatric patients, including those suffering from acute heart failure and cardiogenic shock. The agency ...

Recently, the death of 35-year-old cricketer Imran Patel after a sudden cardiac arrest while walking back to the pavilion during a match has raised questions about why young people, particularly ...

Progress in assessing cardiovascular risk and identifying early prevention opportunities, improvements in treating heart failure, new therapies for bleeding strokes, strategies for reducing the ...

While Japan doesn't typically experience deep-freeze conditions, the winter temperature drop increases the risk of bath-related fatalities caused by what is known as "heat shock,” a sudden ...

Emmy-winning anchor Alisyn Camerota announced she was leaving CNN on what would be her final broadcast Sunday. Her exit after 10 years at the news network seemed to be a surprise. (Watch the video ...

Across Europe, car companies are cutting jobs and shutting factories - to the extent that some question their very existence. So it's worth asking the question: what's gone wrong with Europe (and ...